ASCO's CancerProgress.Net (www.CancerProgress.Net) a dynamic website demonstrating four decades of progress against cancer, has added new resources that will enable site users to learn more about progress in cancer treatment, prevention, screening, and diagnosis.

[Read the rest of this article...]

ASCO and the Institute of Medicine plan to host a workshop Feb. 11-12, 2013, on the continuing efforts to reorganize the nation’s federally-funded cancer clinical trials cooperative group system overseen by the U.S. National Cancer Institute.

[Read the rest of this article...]

On Oct. 26, 2012, the U. S. Food and Drug Administration granted accelerated approval to omacetaxine mepesuccinate, (SYNRIBO® for Injection, for subcutaneous use, Teva Pharmaceutical Industries Ltd.), for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs).

[Read the rest of this article...]

To help advance the important work of community-based investigators and research teams, ASCO held its first annual Community Research Forum on Sept. 1...

[Read the rest of this article...]

On October 19, 2012, the U. S. Food and Drug Administration approved a 90-minute infusion for rituximab (Rituxan® Injection, Genentech, Inc.) star...

[Read the rest of this article...]

ASCO members should have received ASCO’s national survey on the impact of oncology drug shortages on their practice by email on October 6. This questionnaire is intended to help ASCO and its membership understand the impact of legislative and administrative efforts to mitigate drug shortages. 

[Read the rest of this article...]

One Voice Against Cancer, a coalition of public interest groups — including ASCO — representing millions of cancer researchers, doctors and other health professionals, patients, survivors and their loved ones throughout the nation, sent a letter urging members of Congress to work together to avoid across the board budget cuts that would stall progress in the prevention, detection, and treatment of cancer.

[Read the rest of this article...]

In a letter sent to the Senate Finance Committee this week, ASCO joined with more than 100 national and state medical societies in calling on Congress to improve and restructure how Medicare pays for health care in the United States—in a way that would offer physicians an opportunity to shape the future of Medicare, improve the quality of patient care, and decrease healthcare costs.

[Read the rest of this article...]